Dafna Capital Management LLC Bio N Tech Se Transaction History
Dafna Capital Management LLC
- $389 Million
- Q3 2024
A detailed history of Dafna Capital Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Dafna Capital Management LLC holds 8,500 shares of BNTX stock, worth $868,190. This represents 0.26% of its overall portfolio holdings.
Number of Shares
8,500Holding current value
$868,190% of portfolio
0.26%Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
356Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$849 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$461 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$445 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$194 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$185 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...